SYSTEMIC MASTOCYTOSIS DIAGNOSIS-DIAGNOSTIC CRITERIA OR WHO CLASSIFICATION

View at publisher Summarise with VIRAT
Authors: Ezgi Yalcin Gungoren
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Mastocytosis represents a rare group of neoplastic disorders characterized by clonal proliferation of mast cells and a highly heterogeneous clinical spectrum. In the majority of cases, the underlying patho-genic mechanism is constitutive activation of KIT receptor tyrosine kinase signaling pathways. This molecular alteration leads to increased mast cell accumulation and activation, resulting in variable in-volvement of multiple organs, including the skin, bone marrow, gastrointestinal tract, liver, and spleen. The clinical phenotype shows marked interindividual variability and is shaped by the extent of mast cell burden, the distribution of organ infiltration, and the interplay with accompanying genetic or he-matologic factors.

Fields of Study & Subjects

Mast cells and histamine Gastrointestinal Tumor Research and Treatment Histiocytic Disorders and Treatments

Publication details

Journal / source
Turkiye Klinikleri eBooks
Pages
127–139
Publication date
1 January 2026
Language
EN
Document type
Book chapter